Total Payments
$29,938
2024 Payments
$804.28
Companies
50
Transactions
380
Medicare Patients
12,812
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$16,713 (55.8%)
Food & Beverage$8,606 (28.7%)
Travel$4,183 (14.0%)
Consulting$250.00 (0.8%)
Education$185.78 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,700 | 7 | 49.1% |
| Food and Beverage | $8,606 | 349 | 28.7% |
| Travel and Lodging | $4,183 | 17 | 14.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,000 | 1 | 6.7% |
| Consulting Fee | $250.00 | 1 | 0.8% |
| Education | $185.78 | 4 | 0.6% |
| Entertainment | $12.88 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $11,006 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $5,887 | 34 | $0 (2024) |
| Cardiovascular Systems Inc. | $3,470 | 20 | $0 (2021) |
| Boston Scientific Corporation | $2,900 | 67 | $0 (2024) |
| Medtronic, Inc. | $1,190 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $533.06 | 33 | $0 (2024) |
| Abbott Laboratories | $531.46 | 5 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $415.10 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $387.00 | 16 | $0 (2024) |
| PFIZER INC. | $381.03 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $804.28 | 54 | E.R. Squibb & Sons, L.L.C. ($210.70) |
| 2023 | $1,640 | 59 | Medtronic, Inc. ($665.52) |
| 2022 | $1,581 | 47 | Medtronic, Inc. ($451.49) |
| 2021 | $1,458 | 70 | Boehringer Ingelheim Pharmaceuticals, Inc. ($298.65) |
| 2020 | $519.83 | 28 | Amgen Inc. ($104.32) |
| 2019 | $682.10 | 25 | PFIZER INC. ($155.74) |
| 2018 | $10,160 | 47 | Amgen Inc. ($8,505) |
| 2017 | $13,093 | 50 | Novartis Pharmaceuticals Corporation ($5,467) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boston Scientific Corporation | ROTAPRO (Device) | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: ROTAPRO_IC | ||||||
| 12/05/2024 | Imperative Care, Inc | PRODIGY CATHETER (Device) | Food and Beverage | In-kind items and services | $50.18 | General |
| Category: VASCULAR | ||||||
| 12/04/2024 | Medtronic, Inc. | V-LOC 180 (Device) | Food and Beverage | In-kind items and services | $73.02 | General |
| Category: Wound Closure | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.50 | General |
| Category: Cardiovascular | ||||||
| 11/27/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: AVVIGO_IC | ||||||
| 11/20/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: AVVIGO_IC | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $3.44 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Boston Scientific Corporation | Comet (Device) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Comet_IC | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: AVVIGO_IC | ||||||
| 10/23/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: AVVIGO_IC | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Cardiovascular | ||||||
| 10/04/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.81 | General |
| Category: Cardiovascular | ||||||
| 09/04/2024 | Boston Scientific Corporation | SYNERGY (Device) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: SYNERGY_IC | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.55 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $3.01 | General |
| Category: Cardiovascular | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.08 | General |
| Category: Cardiovascular | ||||||
| 07/29/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: AVVIGO_IC | ||||||
| 07/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.16 | General |
| Category: Cardiovascular | ||||||
| 07/15/2024 | Boston Scientific Corporation | Comet (Device) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Comet_IC | ||||||
| 07/12/2024 | Reflow Medical Inc | — | Food and Beverage | Cash or cash equivalent | $20.22 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,283 | 5,257 | $954,692 | $446,120 |
| 2022 | 40 | 3,383 | 7,229 | $962,298 | $452,743 |
| 2021 | 39 | 3,361 | 6,994 | $1.0M | $469,266 |
| 2020 | 38 | 2,785 | 7,119 | $873,207 | $432,893 |
Total Patients
12,812
Total Services
26,599
Medicare Billing
$1.8M
Procedure Codes
164
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 497 | 925 | $96,200 | $59,632 | 62.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 168 | 170 | $123,080 | $58,766 | 47.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 250 | 696 | $86,846 | $44,050 | 50.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 229 | 235 | $94,000 | $33,685 | 35.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 168 | 342 | $102,600 | $27,853 | 27.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 40 | 40 | $36,000 | $25,509 | 70.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 132 | 536 | $40,200 | $22,676 | 56.4% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 17 | 21 | $52,500 | $21,642 | 41.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 121 | 198 | $29,304 | $18,999 | 64.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 271 | 350 | $21,700 | $15,031 | 69.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 24 | 26 | $26,000 | $12,409 | 47.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 96 | 114 | $22,686 | $11,558 | 50.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 73 | $21,243 | $9,874 | 46.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 60 | 65 | $19,500 | $9,147 | 46.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 47 | 48 | $24,000 | $8,326 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 79 | $11,850 | $7,511 | 63.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 51 | 51 | $22,950 | $7,265 | 31.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 127 | 130 | $14,200 | $6,881 | 48.5% |
| 92943 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | Facility | 2023 | 11 | 11 | $11,000 | $5,742 | 52.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 71 | 71 | $11,076 | $5,362 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $8,843 | $4,423 | 50.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 352 | 448 | $15,680 | $4,387 | 28.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 20 | 20 | $9,140 | $3,743 | 40.9% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 31 | 41 | $12,300 | $3,571 | 29.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 39 | 61 | $5,246 | $3,368 | 64.2% |
About Dr. George Nahhas, M.D
Dr. George Nahhas, M.D is a Cardiovascular Disease healthcare provider based in Dearborn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427084805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Nahhas, M.D has received a total of $29,938 in payments from pharmaceutical and medical device companies, with $804.28 received in 2024. These payments were reported across 380 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,700).
As a Medicare-enrolled provider, Nahhas has provided services to 12,812 Medicare beneficiaries, totaling 26,599 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Dearborn, MI
- Active Since 06/25/2006
- Last Updated 03/25/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427084805
Products in Payments
- Repatha (Biological) $10,953
- ENTRESTO (Drug) $5,829
- Coronary Orbital Atherectomy System (Device) $3,201
- GENERAL - VASCULAR ACCESS (Device) $1,392
- MICRA (Device) $1,117
- ELIQUIS (Drug) $546.00
- XARELTO (Drug) $533.06
- JARDIANCE (Drug) $387.00
- Optis Coronary Imaging System (Device) $362.52
- Impella (Device) $339.86
- VERQUVO (Drug) $239.90
- Peripheral Orbital Atherectomy System (Device) $208.52
- BRILINTA (Drug) $200.53
- CAMZYOS (Drug) $198.48
- VARITHENA (Drug) $179.10
- AVVIGO Guidance System (Device) $177.21
- FFRangio (Device) $169.35
- Quadra Assura CRT Defibrillator (Device) $148.85
- LifeVest (Device) $127.83
- GENERAL STENTS (Device) $126.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Dearborn
Dr. Ashok Kondur, M.d, M.D
Cardiovascular Disease — Payments: $79,693
Cardiovascular Disease $79,693
Dr. Nishit Choksi, M.d, M.D
Cardiovascular Disease — Payments: $51,940
Cardiovascular Disease $51,940
Rita Coram
Cardiovascular Disease — Payments: $25,923
Cardiovascular Disease $25,923
Raid Saco, Md, MD
Cardiovascular Disease — Payments: $14,534
Cardiovascular Disease $14,534
Omar Ali, M.d, M.D
Cardiovascular Disease — Payments: $14,396
Cardiovascular Disease $14,396
Dr. Samer Salka, M.d, M.D
Cardiovascular Disease — Payments: $12,689
Cardiovascular Disease $12,689